News
Policy & Recommendations
Why health should be at the heart of building a more secure and competitive Europe
Five years ago this month, governments across Europe implemented unprecedented lockdowns in response to the onset of the Covid-19 pandemic. It brought home to us the risks we face and the costs of complacency and a lack of preparedness.
What COVID-19 taught us about protecting kids in future pandemics
Five years after the World Health Organization declared COVID-19 a global pandemic, infectious disease experts continue to draw on its lessons for future disasters.
XBB.1.5 monovalent vaccine induces lasting cross-reactive responses to SARS-CoV-2 variants such as HV.1 and JN.1, as well as SARS-CoV-1, but elicits limited XBB.1.5 specific antibodies
The evolution of the antibody response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is impacted by the nature and number of antigenic exposures.
News
Policy & Recommendations
Joint Action on REspiratory Diseases (JARED) launched
A new joint action focusing on tackling chronic respiratory diseases was recently launched. Backed by the EU4Health programme, the 3-year initiative aims to improve lung health across Europe through innovative digital health technologies.
|
ESWI Airborne: Intervention Strategies of Acute Respiratory Virus Infections
If you do not test, you will not know - a focus on COVID-19
A riveting episode from three unique perspectives on intervention strategies and the ongoing challenges posed by Sars-Cov-2, the virus behind one of the deadliest pandemics in recent history.
Health in the age of disinformation
Health misinformation and disinformation are not new, but the COVID-19 pandemic marked a turning point. Health misinformation was weaponised as propaganda, exploiting fear, undermining public trust, and hindering collective action in critical moments.
SARS-COV-2 re-infection and incidence of post-acute sequelae of COVID-19 (PASC) among essential workers in New York: a retrospective cohort study
After surviving Coronavirus Disease 2019 (COVID-19), some people develop symptoms known as post-acute sequelae of COVID-19 (PASC). PASC is an emerging phenomenon yet to be fully understood, and identifying risk factors has been challenging.
News
Policy & Recommendations
ECDC launches RespiCompass, a scenario modelling hub for respiratory diseases
ECDC has launched an online platform, RespiCompass, which uses mathematical modelling to simulate respiratory disease dynamics under different scenarios.